CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15,895 enrolled
Drug / intervention
improvement of quality of stroke carebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03578107
NCT03578107N/ACompleted
CompareCT.gov

Improve Acute Reperfusion Treatment Quality for Stroke in China

Beijing Tiantan Hospital·interventional·Posted Jul 5, 2018·Updated Nov 2, 2021

In Brief

A clinical study evaluating improvement of quality of stroke care for Ischemic Stroke. Completed, enrolled 15,895 participants across 1 site.

Detailed Summary

In order to bridge the great gaps, Chinese Stroke Association (CSA) and American Heart Association (AHA) sought to develop, conduct, and assess a multifaceted quality improvement intervention to increase the adherent rate of IV tPA and ET and improve 3-month clinical outcomes for these patients through our cluster-randomized stepped-wedge IMPROVE: Stroke in China trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesChina
CollaboratorsAmerican Heart Association

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 5, 2018
Enrollment StartJul 1, 2018
Primary CompletionJul 31, 2020
Study CompletionOct 31, 2020
TodayJul 1, 2026
Enrollment to primary: 2.1 yearsPosted 8.0 years ago

Interventions

improvement of quality of stroke carebehavioral

1. hospital tool kits for quality improvement of reperfusion therapy ; 2. organizational stakeholder and opinion leader meetings; 3. data monitoring and feedback reports； 4. webinar for hospital teams